Pancreatic Cancer Research

ResearcherEhime UniversityActive in the last 2 years

Kaori Hino

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9046-253X; OpenAlex author ID A5022620188. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. A multicenter prospective observational study for health assessment questionnaires EQ-5D-5L and G8 in unresectable advanced pancreatic cancer treated with firs… Co-author DOI 10.1007/s10147-025-02717-1↗
  2. Clinical Outcomes of S-1 Monotherapy and Modified FOLFIRINOX Therapy after Gemcitabine plus Nab-paclitaxel Therapy in Unresectable Pancreatic Cancer. Co-author DOI 10.2169/internalmedicine.8736-21↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Akinori Asagi · 2 shared papers, 2022–2025 · strength 0.32
  2. Mitsuhito Koizumi · 2 shared papers, 2022–2025 · strength 0.32
  3. Ichinosuke Hyodo · 2 shared papers, 2022–2025 · strength 0.32
  4. Teru Kumagi · 2 shared papers, 2022–2025 · strength 0.32
  5. Yoichi Hiasa · 2 shared papers, 2022–2025 · strength 0.32
  6. Yoshinori Ohno · 1 shared paper, 2025 · strength 0.20
  7. Toru Otsuru · 1 shared paper, 2025 · strength 0.20
  8. Taira Kuroda · 1 shared paper, 2025 · strength 0.20
  9. Yuki Numata · 1 shared paper, 2025 · strength 0.20
  10. Takashi Terao · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.